Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth E Hanchrow

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Studies in Health Technology and Informatics|August 8, 2025
Enhancing and Disaggregating Native Hawaiian and Pacific Islander (NHPI) Data Using Natural Language Processing and an Expanded Race/Ethnicity LexiconBenjamin Viernes, Qiwei Gan, Elizabeth E Hanchrow, et al.
Studies in Health Technology and Informatics|August 8, 2025
Development and Evaluation of Natural Language Processing Methods for Extracting Key Melanoma Pathology ConceptsJohnathan C Stanley, Mengke Hu, Cecelia J Madison, et al.
JCO Clinical Cancer Informatics|February 10, 2025
Incorporating Structured and Unstructured Data Sources to Identify and Characterize Hereditary Cancer Testing Among Veterans With Metastatic Castration-Resistant Prostate CancerDanielle Candelieri-Surette, Anna Hung, Fatai Y Agiri, et al.
BMJ Medicine|October 13, 2023
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Lovedeep Singh Dhingra, Arya Aminorroaya, et al.
Journal of the American College of Cardiology|August 28, 2024
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DMRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudyRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Studies in Health Technology and Informatics|August 8, 2025
Enhancing and Disaggregating Native Hawaiian and Pacific Islander (NHPI) Data Using Natural Language Processing and an Expanded Race/Ethnicity LexiconBenjamin Viernes, Qiwei Gan, Elizabeth E Hanchrow, et al.
Studies in Health Technology and Informatics|August 8, 2025
Development and Evaluation of Natural Language Processing Methods for Extracting Key Melanoma Pathology ConceptsJohnathan C Stanley, Mengke Hu, Cecelia J Madison, et al.
JCO Clinical Cancer Informatics|February 10, 2025
Incorporating Structured and Unstructured Data Sources to Identify and Characterize Hereditary Cancer Testing Among Veterans With Metastatic Castration-Resistant Prostate CancerDanielle Candelieri-Surette, Anna Hung, Fatai Y Agiri, et al.
BMJ Medicine|October 13, 2023
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Lovedeep Singh Dhingra, Arya Aminorroaya, et al.
Journal of the American College of Cardiology|August 28, 2024
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DMRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudyRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Pageof 1